Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease

Journal of the Neurological Sciences

Volumn 151, Issue 2, 1997, Pages 159-162

  Mally, Judit ^a   Szalai, Gabriella ^b   Stone, T W ^c  

^a Erzsebet Korhaz ^*  (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Amino acids; Glutamate; Glutamine; Parkinson's disease; Tremor

Indexed keywords

DOPAMINE; GLUTAMIC ACID;

ADULT; AGED; AMINO ACID ANALYSIS; AMINO ACID METABOLISM; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEUROTRANSMISSION; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; TREMOR;

AGED; AMINO ACIDS; GLUTAMIC ACID; HUMANS; PARKINSON DISEASE;

EID: 0030748917     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00119-6     Document Type: Article

References (17)

1. Bartok, T., Szalai, G., Lorincz, Z., Borcsok, G., Sagi, F., 1994. High speed reverse phase HPLC/FI analysis of amino acids after automated two-step derivatisation with o-phthaldialdehyde/3-mercaptopropionic acid and 9-fluorenylmethylchloroformate. J. Liq. Chromatogr. 17, 4391-4403.
2. Bruck, H., Gerstenbrand, F., Grunding, E., Teuflmayer, R., 1964. Uber ergebnisse von Liqoranalysen beim Parkinson-syndrom. Acta Neuropathol. 3, 638-644.
3. +. J. Neural Trans. (Parkinson's disease section) 7, 167-176.
4. Grundig, E., Gerstenbrand, F., 1970. Uber den Zusammenhang zwischen der Parkinson-Symptomatik und einer Storung des Amino-saurehaushaltes im ZNS. Klin. Wochenschr. (Wien) 82, 811-816.
5. Iwasaki, Y., Ikeda, K., Shiojima, T., Kinoshita, M., 1992. Increased plasma concentrations of aspartate, glutamate and glycine in Parkinson's disease. Neurosci. Lett. 145, 175-177.
6. Jimenez-Jimenez, F.J., Molina, J.A., Vargas, C., Gomez, P., Navarro, J.A., Benito-Leon, J., Orti-Pareja, M., Gasalla, T., Cisneros, E., Arenas, J., 1996. Neurotransmitter amino acids in CSF of patients with Parkinson's disease. J. Neurol. Sci. in press.
7. Klockgether, T., Turski, L., 1989. Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease. Trends Neurosci. 12, 285-286.
8. Kornhuber, J., Kornhuber, M.E., Hartmann, G.M., Kornhuber, A.W., 1988. In vivo influences on CSF amino acid levels. Neurochem. Int. 12, 25-31.
9. Kornhuber, M.E., Balabanova, S., Heiligensetzer, G.V., Kornhuber, C., Zettlmeisl, H., Kornhuber, A.W., 1991. Stability of human blood serum amino acids after storage at different pH and temperature conditions. Clin. Chim. Acta 197, 189-200.
10. Lakke, J.P., Teelken, A.W., 1976. Amino acid abnormalities in cerebrospinal fluid of patients with Parkinsonism and extrapyramidal disorders. Neurology 26, 489-493.
11. Lakke, J.P., Teelken, A.W., van derVoet, H., Wolthers, B.G., 1987. Amino acid abnormalities in CSF and blood serum of patients with Parkinson's disease, other neurodegenerative disorders and head injuries. Adv. Neurol. 45, 243-247.
12. Manyam, B.V., Ferraro, T.N., Hare, T.A., 1988. Cerebrospinal fluid amino compounds in Parkinson's disease: alterations due to carbidopa/levodopa. Arch. Neurol. 45, 48-50.
13. Perschak H., Amsler, U., Vischer, A., Siegfried, A., Cuenod, M., 1987. Ventricular CSF concentrations of putative amino acid transmitters in Parkinson's disease and other disorders. Hum. Nerurobiol. 6, 191-194.
14. Starr, M.S., 1995. Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse 19, 264-293.
15. Stone, T.W. (Ed.), 1996. CNS Neurotransmitters and Neuromodulators: Glutamate. CRC Press, Boca Raton, FL.
16. Tohgi, H., Abe, T., Hashiguchi, K., Takahashi, S., Nozaki, Y., Kikuchi, T., 1991. A significant reduction of putative transmitter amino acids in CSF of patients with Parkinson's disease and spinocerebellar degeneration. Neurosci. Lett. 126, 155-158.
17. Zipp, F., Burklin, F., Stecker, K., Baas, H., Fischer, P.A., 1995. Lamotrigine in Parkinson's disease - a double blind study. J. Neural Trans. (Parkinson's disease section) 10, 199-206.